Avoid common mistakes on your manuscript.
Correction to: Cancer Immunology, Immunotherapy https://doi.org/10.1007/s00262-020-02536-5
The original version of this article unfortunately contained a mistake. The second sentence of the section “irAEs and ICI efficacy” should read as
Patients with irAEs had a higher objective response rate (ORR) compared with patients with no-irAEs 40.1% (4.9% CR + 35.2% PR) versus 14.1% [(2.1% CR + 12.1% PR); p < 0.01].
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Naqash, A.R., Ricciuti, B., Owen, D.H. et al. Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort. Cancer Immunol Immunother 69, 1189 (2020). https://doi.org/10.1007/s00262-020-02582-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-020-02582-z